MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
iRhythm Technologies General and Administrative Expenses 2011-2026 | IRTC
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses iRhythm Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 493 M | 419 M | 386 M | 322 M | 275 M | 197 M | 180 M | 132 M | 84.7 M | 51.6 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 493 M | 51.6 M | 254 M |
Quarterly General and Administrative Expenses iRhythm Technologies
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 136 M | - | 126 M | 120 M | - | 103 M | 107 M | 109 M | - | 93.8 M | 91.4 M | 100 M | - | 80.6 M | 81.8 M | 73.2 M | - | 70.7 M | 62.7 M | 69.8 M | - | 49.7 M | 43 M | 48.2 M | - | 45.6 M | 42.2 M | 38.1 M | - | 133 M | 33.9 M | 29.8 M | - | 20.3 M | 20.3 M | 17.2 M | - | 12.5 M | 12.6 M | 11.5 M | - | 9.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 136 M | 9.44 M | 64.3 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 66.7 | 7.55 % | $ 13.3 B | USA |
 |
Glaukos Corporation
GKOS
|
332 M | $ 125.46 | 3.01 % | $ 7.18 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
2.38 B | $ 424.69 | 1.4 % | $ 152 B | USA |
 |
Alcon
ALC
|
251 M | $ 66.76 | 0.3 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
625 M | $ 137.0 | 1.53 % | $ 3.38 B | USA |
 |
Repro Med Systems
KRMD
|
23.4 M | $ 4.0 | -3.38 % | $ 185 M | USA |
 |
LeMaitre Vascular
LMAT
|
42 M | $ 95.09 | 1.64 % | $ 2.15 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 178.89 | -0.01 % | $ 9.53 B | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
8.46 M | $ 1.86 | -5.1 % | $ 85.2 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
9.99 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
11.6 M | $ 0.4 | -7.05 % | $ 32.8 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
38.2 M | $ 9.02 | -9.26 % | $ 76.5 K | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 22.93 | 0.28 % | $ 3.85 B | USA |
 |
Haemonetics Corporation
HAE
|
442 M | $ 71.55 | 2.48 % | $ 3.38 B | USA |
 |
STERIS plc
STE
|
1.41 B | $ 211.87 | -0.19 % | $ 20.8 B | USA |
 |
Isoray
ISR
|
30.2 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
85.8 M | $ 29.76 | -0.33 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
57 M | $ 9.27 | 1.26 % | $ 191 M | USA |
 |
Teleflex Incorporated
TFX
|
720 M | $ 131.06 | -0.76 % | $ 5.85 B | USA |
 |
Utah Medical Products
UTMD
|
7.88 M | $ 68.72 | 1.08 % | $ 223 M | USA |
 |
Merit Medical Systems
MMSI
|
455 M | $ 64.16 | 1.78 % | $ 3.8 B | USA |
 |
West Pharmaceutical Services
WST
|
394 M | $ 317.18 | -0.03 % | $ 22.9 B | USA |
 |
Pulse Biosciences
PLSE
|
32 M | $ 25.34 | -5.94 % | $ 1.71 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.44 B | $ 9.9 | 0.2 % | $ 1.97 B | USA |
 |
Retractable Technologies
RVP
|
12.8 M | $ 0.66 | -0.05 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 67.35 | 0.52 % | $ 221 M | USA |
 |
Predictive Oncology
POAI
|
25.9 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
45.5 M | $ 26.47 | -2.31 % | $ 1.26 B | USA |
 |
Stereotaxis
STXS
|
17.8 M | $ 1.8 | -4.26 % | $ 164 M | USA |
 |
Baxter International
BAX
|
2.89 B | $ 19.36 | 0.05 % | $ 9.93 B | USA |
 |
ResMed
RMD
|
739 M | $ 195.29 | 0.51 % | $ 28.5 B | USA |
 |
AtriCure
ATRC
|
311 M | $ 27.27 | -0.02 % | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
17.7 M | $ 6.16 | -5.02 % | $ 273 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 12.22 | 1.58 % | $ 499 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 152.33 | 1.91 % | $ 43.8 B | USA |
 |
Nephros
NEPH
|
9 M | $ 3.5 | -2.51 % | $ 37.1 M | USA |
 |
OraSure Technologies
OSUR
|
47.7 M | $ 4.01 | -3.72 % | $ 295 M | USA |
 |
Repligen Corporation
RGEN
|
291 M | $ 122.83 | -2.94 % | $ 6.91 M | USA |